Adira is a Digital Platform for use in the Treatment of Eating Disorders. By digitizing evidence based treatment methodologies Adira addresses the challenges of scale and accessibility, offering high quality interventions to people suffering from eating disorders, regardless of diagnosis or severity. Using Machine-Learning based tools we monitor, analyze and optimize treatment offering a personalized user experience. This allows for ever improving results, as we create the largest interactive ED treatment database. We’re launching our clinically validated system in 2023. Additionally we plan to seek a Class II medical device clearance from the FDA. The MVP we are currently piloting in the USA is a chatbot technology that covers various scenarios commonly encountered by people with eating disorders. Adira offers effective treatment options to help users improve nutrition, body image and cope with the urges, thoughts and beliefs that are barriers to recovery. Using familiar Interfaces, we provide clinically validated digital tools to augment human treatment for medium and severe cases, and that may be the primary tool for milder cases.
